Stock Price Forecast

March 28, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Resmed Inc. chart...

About the Company

at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.

CEO

Michael Farrell

Exchange

NEW YORK STOCK EXCHANGE INC.

Website

https://www.resmed.com/

$704M

Total Revenue

5K

Employees

$29B

Market Capitalization

32.58

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $RMD News

ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 Device

1mon ago, source: Zacks.com on MSN

ResMed, Inc. RMD recently introduced its AirCurve 11 series devices. These are the company’s newest bilevel devices that use ...

ResMed Inc.

2mon ago, source: CNN

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK)

1d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Resmed (RMD – Research Report) and Merck ...

GLP-1 obesity medicines do the opposite of what ResMed stock investors feared

14d ago, source:

ResMed Inc (ASX: RMD) stock investors may find the company's research on the impact of GLP-1 drugs like Ozempic extremely ...

ASX: ResMed Inc stock analysis and Elliott Wave technical forecast [Video]

8d ago, source:

Greetings, Our Elliott Wave analysis todaya updates the Australian Stock Exchange (ASX) with RMD – RESMES INC shares. We have ...

ResMed Inc BRDR R1MD34

28d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ResMed Inc.: ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

14d ago, source: Finanznachrichten

SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea, ...

Q2 2024 Resmed Inc Earnings Call

2mon ago, source: Yahoo Finanzas

Q2 2024 Resmed Inc Earnings Call Q2 2024 Resmed Inc Earnings Call INICIO CORREO NOTICIAS FINANZAS DEPORTES CELEBRIDADES VIDA Y ESTILO MÁS... Yahoo Finanzas Iniciar sesión Correo Inicia sesión para ver ...

ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)

1mon ago, source: Zacks.com on MSN

ResMed, Inc. RMD recently introduced its AirCurve 11 series devices -- the company’s newest bilevel devices that use two ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...